anxiety, pain or choking during the procedure. About 93 percent said they would do it again.
“We wanted an easier, less costly test that could provide a practical way for screening and early detection of individuals with Barrett’s esophagus, who can then be followed closely to prevent the development of [esophageal cancer],” Chak said.
A report on the device and the clinical trial results were published in Science Translational Medicine.
For more information on gastroesophageal (GEJ) junction cancer, visit our Health Conditions page on BlackDoctor.org.
SOURCE: Case Western Reserve University, news release, Jan. 17, 2018